Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study

El-Khoury H*, Lee DJ*, Alberge JB*, Redd R, Cea-Curry CJ, Perry J, Barr H, Murphy C, Sakrikar D, Barnidge D, Bustoros M, Leblebjian H, Cowan A, Davis MI, Amstutz J, Boehner CJ, Lightbody ED, Sklavenitis-Pistofidis R, Perkins MC, Harding S, Mo CC, Kapoor P, Mikhael J, Borrello IM, Fonseca R, Weiss ST, Karlson E, Trippa L, Rebbeck TR, Getz G#, Marinac CR#, Ghobrial IM#^
Lancet Haematology 22 (2022)

Abstract

. Lancet Haematol. 2022 Mar 25:S2352-3026(22)00069-2. doi: . Epub ahead of print. PMID: .

Getz Lab Authors
* First Authors
# Senior Authors
^ Corresponding Authors
Full text
Pubmed
DOI
Dimensions
(# of citations)
Altmetrics
Share
tweet